Versa Vascular appoints Bill Shields as CEO and announces $15 million in expanded Series C funding.
Amount Raised
$15 Million
Round Type
Series C
Santa CruzBiotechnologyHealth CareMedicalMedical DeviceInvestors
Description
Versa Vascular has expanded its Series C funding by securing an additional $15 million. The company continues to grow under the leadership of newly appointed CEO Bill Shields. This funding will help propel its ongoing initiatives. Investors are showing increased confidence in the company's vision and strategy.
Who to call at Versa Vascular, and when
A new round usually means Versa Vascular is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Versa Vascular raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Versa Vascular, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Versa Vascular. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Versa Vascular raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Versa Vascular raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.